Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.

Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise / Aydin S.Z.; Direskeneli H.; Merkel P.A.; Toloza S.; Blockmans D.; Sato E.I.; De Souza A.W.S.; Cabral D.; Carette S.; Famorca L.; Khalidi N.; Milman N.; Yacyshyn E.; Tesar V.; Baslund B.; Faurschou M.; Guillevin L.; Puechal X.; Aries P.; Hellmich B.; Herlyn K.; Holle J.; Lamprecht P.; Moosig F.; Neumann T.; Zwerina J.; Tomasson G.; Bambery P.; Jois R.; Rajasekhar L.; Sharma A.; Sivakumar R.; Molloy E.; Hashkes P.; Catapano F.; Cimino L.; De Fanti A.; Pipitone N.; Salvarani C.; Vaglio A.; Kobayashi S.; Suzuki K.; Flores-Suarez L.F.; Hinojosa-Azaola A.; Brouwer E.; Rutgers A.; Stegeman C.; Suppiah R.; Hollan I.; Arguis P.; Cid M.C.; Daikeler T.; Alibaz-Oner F.; Hamuryudan V.; Hatemi G.; Hazirolan T.; Inanc M.; Kalayci M.B.; Kamali S.; Kansu T.; Karaaslan Y.; Karadag O.; Keser G.; Onat A.M.; Ozbalkan Z.; Ozen S.; Ozer H.T.E.; Pamuk O.N.; Yilmaz S.G.; Basu N.; Casian A.; Chakravarty K.; D'Cruz D.; Edelsten C.; Harper L.; Jayne D.; Levy J.; Mason J.; Robson J.; Scott D.; Stanford M.; Watts R.; Albert D.; Amudala N.; Beckman J.; Chacko B.; Chung S.; Fessler B.; Giardino A.; Grayson P.; Hunder G.; Langford C.; Lerman M.; Liang K.; Litt H.; Mason T.; Matteson E.; Mikdashi J.; Mohler E.; Monach P.; Rice B.; Sharma A.; Sreih A.; Stone J.; Tsapatsaris N.; Villa-Forte A.; Warrington K.; Yazici Y.; Ytterberg S.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - ELETTRONICO. - 44:(2017), pp. 1928-1932. [10.3899/jrheum.161269]

Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise

Vaglio A.
Membro del Collaboration Group
;
2017

Abstract

Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
2017
44
1928
1932
Goal 3: Good health and well-being for people
Aydin S.Z.; Direskeneli H.; Merkel P.A.; Toloza S.; Blockmans D.; Sato E.I.; De Souza A.W.S.; Cabral D.; Carette S.; Famorca L.; Khalidi N.; Milman N....espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1217316
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact